Interest of the Virtual Reality Headset in the Management of Perioperative Stress in Patients Candidates for Total Thyroidectomy (ThyroVir)

September 15, 2025 updated by: Centre Francois Baclesse
Study the interest of hypnosis techniques by virtual reality based on the use of a virtual reality headset with the AQUA® application on the reduction of pre-operative stress in patients candidates for total thyroidectomy

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

82

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Caen, France
        • CHU caen
      • Caen, France
        • Centre Francois Baclesse
      • Rouen, France
        • Clinique Mathilde

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient> 18 years old
  • Man or woman
  • Patient candidate for a total thyroidectomy, or a thyroid totalization
  • Preoperative Euthyroidism
  • Can justify outpatient care: score of the American Society of Anesthesiology (ASA) 1, 2 or 3 stable; accompanied for return at home; can be watched by a loved one the night after returning home; reachable by telephone; living within an hour of transportation from a hospital and having a good level of understanding.
  • No history of parathyroid or recurrent pathology
  • Signature of informed consent before any specific procedure related to the study
  • Subject affiliated with a health security system

Exclusion Criteria:

  • Patient with a submerged goiter (lower edge of the thyroid not seen on the preoperative cervical ultrasound)
  • Patient with uncontrolled infectious pathology
  • Pregnant or breastfeeding woman or lack of contraception during genital activity
  • Patient with illnesses or conditions that hinder their ability to understand follow and / or comply with study procedures
  • Patient with personality disorders and / or psychiatric pathology
  • Patient deprived of liberty or placed under the authority of a guardian

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: using a virtual reality headset

The intervention will consist of 2 sessions of 30 minutes each, based on the use of a virtual reality headset with the AQUA® application.

  • The 1st session will take place on the day of the surgical intervention, upon arrival in hospital, after reception in the room.
  • The 2nd session will take place the same day, post-operatively, once the awakening is satisfactory (within 3 to 6 hours after the intervention)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Anxiety state (STAI-Y scale)
Time Frame: Before surgery and up to 2 hours after surgery
The proportion of patients whose pre-operative anxiety state (STAI-Y scale)is improved or stable between before and after the session with virtual reality headset. These two measurements will allow us to appreciate the variations in patient anxiety.
Before surgery and up to 2 hours after surgery
Change of Anxiety state(AE scale)
Time Frame: Before surgery and up to 2 hours after surgery
The proportion of patients whose preoperative anxiety state (AE) is improved or stable between before and after the session with virtual reality headset. These two measurements will allow us to appreciate the variations in patient anxiety.
Before surgery and up to 2 hours after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anxiety evaluation by Amsterdam Preoperative Anxiety and Information Scale (APAIS)
Time Frame: up to 1 month after surgery
Anxiety score [minimum value 0 , up to maximum value (worse) 20] according to the Amsterdam Pre-operative Anxiety and Information Scale (APAIS)
up to 1 month after surgery
Pain evaluation (Visual Analog Pain Scale)
Time Frame: up to 1 month after surgery
Score on the VAS pain scale [minimum value 0, up to maximum value (worse) 10]
up to 1 month after surgery
Satisfaction of patients by EVAN-G scale (Evaluation of the General Anesthesia feelings)
Time Frame: Up to 2 hours after surgery
score of EVAN-G questionnaire [minimum value 0, up to maximum value (worse) 100]
Up to 2 hours after surgery
Taking of anxiolytics
Time Frame: up to 1 month after surgery
variation of amount of anti-anxiety medication
up to 1 month after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 18, 2020

Primary Completion (Actual)

June 6, 2025

Study Completion (Actual)

June 6, 2025

Study Registration Dates

First Submitted

July 7, 2020

First Submitted That Met QC Criteria

July 21, 2020

First Posted (Actual)

July 22, 2020

Study Record Updates

Last Update Posted (Estimated)

September 18, 2025

Last Update Submitted That Met QC Criteria

September 15, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Thyroid Cancer

Clinical Trials on Use of a virtual reality headset

Subscribe